by Talking Medicines | Jan 31, 2024
In collaboration with our partners at Sermo, our Advanced Data Science and Artificial Intelligence solutions played a crucial role in uncovering previously unseen intelligence about GLP-1 and GIP/GLP-1. This report is designed to comprehend challenges, perceptions,...
by Talking Medicines | Jan 22, 2024
In the fast-evolving landscape of Healthcare Marketing, the dominance of Artificial Intelligence (AI) is revolutionizing the game. With Advanced Data Science and AI leading the charge, we are not just talking about trends; we are entering an era where being data-first...
by Talking Medicines | Dec 1, 2023
We’re delighted to be showcased in the SIS Ventures inaugural Impact Report, sharing space with an incredible portfolio of companies. Our journey, commitment, and progress underscore the impactful strides we’ve taken alongside the SIS Ventures team....
by Talking Medicines | Nov 9, 2023
As the COVID pandemic unfolded, pharmaceutical companies were suddenly thrust into the limelight with the virus becoming a household topic. Fast forward three and a half years, these very same companies are now rolling out their updated mRNA Covid-19 vaccines...
by Talking Medicines | Oct 18, 2023
As we navigate the journey of life, we often encounter significant milestones and transitions, one of which is menopause. Menopause is a natural phase in a woman’s life, marking the end of her reproductive years. It’s a topic that has been shrouded in...